Organophosphorus management in peds

Reading File
Finding Sources
Searching PubMed

organophosphate poisoning children management

Finding Sources
Searching PubMed

organophosphate poisoning pediatric atropine pralidoxime

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content to write a thorough answer. Let me compile everything.

Organophosphate (OP) Poisoning: Pediatric Management

Why Children Are More Vulnerable

Children carry greater risk than adults for several reasons:
  • Smaller body mass means a given dose produces higher mg/kg exposure
  • Lower baseline cholinesterase activity - less enzyme reserve means inhibition reaches toxic threshold faster
  • Higher surface area-to-body-mass ratio increases transdermal absorption
  • Developing nervous systems are more sensitive to neurotoxic effects, including the neurodevelopmental effects of chronic low-level exposure
Organophosphates are absorbed via dermal, GI, inhalation, and conjunctival routes - all relevant in pediatric exposures (flea dips, agricultural spray, contaminated food, household products). - Tintinalli's Emergency Medicine, p. 1342

Pathophysiology (Brief Recap)

OPs irreversibly phosphorylate acetylcholinesterase (AChE), leading to acetylcholine (ACh) accumulation at:
  • Muscarinic sites (exocrine glands, smooth muscle, heart)
  • Nicotinic sites (skeletal muscle neuromuscular junction, autonomic ganglia)
  • CNS sites
"Aging" = permanent irreversible AChE-OP bonding - time to aging varies from minutes to >24 hours depending on agent. Once aged, new enzyme synthesis (weeks) is the only recovery route. - Tintinalli's Emergency Medicine, p. 1343

Clinical Presentation

Muscarinic (SLUDGE / DUMBELS):
SLUDGEDUMBELS
SalivationDefecation, Urination, Miosis
LacrimationBradycardia, Bronchospasm, Bronchorrhea
UrinationEmesis
DefecationLacrimation
GI crampingSalivation
Emesis
Also: miosis, bronchospasm/bronchorrhea (the primary killer), bradycardia, hypotension.
Nicotinic:
  • Muscle fasciculations, cramps, weakness
  • Progression to paralysis and areflexia (can mask seizure activity)
  • Respiratory muscle paralysis - the most common cause of death
CNS:
  • Anxiety, restlessness, seizures, coma
Key pediatric note: The majority of severely poisoned patients have altered mental status, pinpoint pupils, diaphoresis, and respiratory distress. - Tintinalli's Emergency Medicine, p. 1343

Four Recognized Clinical Syndromes

  1. Acute cholinergic crisis - immediate onset, classic SLUDGE/nicotinic/CNS findings
  2. Intermediate syndrome - 1-5 days post-exposure, seen in up to 40% after ingestion; neck flexor and proximal limb paralysis, cranial nerve involvement, respiratory failure (no cholinergic excess); resolves within ~7 days
  3. Chronic toxicity - symmetrical sensorimotor axonopathy (mostly agricultural workers)
  4. OP-induced delayed neuropathy - cognitive dysfunction, peripheral neuropathy, extrapyramidal signs - Tintinalli's Emergency Medicine, p. 1343

Management

Step 1: Decontamination

  • Remove clothing (can reduce ongoing absorption by up to 80%)
  • Wash skin and hair thoroughly with soap and water
  • Eye irrigation for ocular exposure
  • Healthcare staff must use PPE (gloves, gown) to avoid secondary contamination

Step 2: Airway & Respiratory Support

  • This is the priority - death is from respiratory failure
  • Early endotracheal intubation for respiratory muscle weakness, excessive secretions, or declining consciousness
  • Succinylcholine should be avoided (or used cautiously) - OP inhibits pseudocholinesterase, prolonging neuromuscular blockade; use rocuronium instead if paralysis needed
  • Suction bronchorrhea aggressively

Step 3: Atropine (Anti-muscarinic Antidote)

Atropine is the cornerstone of treatment.
ParameterPediatric Dose
Initial IV/IO bolus0.05 mg/kg IV
Repeat intervalEvery 5-10 minutes, doubling each dose
EndpointDrying of respiratory secretions + improved respiratory effort + normalization of respiratory rate
Maintenance infusion (once stabilized)10-20% of total loading dose per hour
  • Tachycardia and mydriasis are not endpoints to stop atropine - only secretion drying is
  • Expect very large total doses (200-500 mg in adults; children proportionally large) - do not be alarmed
  • Atropine does not reverse nicotinic effects (muscle paralysis, fasciculations)
    • Rosen's Emergency Medicine, p. 1492

Step 4: Pralidoxime / 2-PAM (Oxime - AChE Reactivator)

Pralidoxime reactivates phosphorylated AChE if given before aging occurs.
Indications: Moderate-severe poisoning - defined as requiring multiple large atropine doses, respiratory depression/failure, fasciculations, seizures, dysrhythmias, hemodynamic instability.
ParameterPediatric Dose
Loading dose25-50 mg/kg IV over 30 minutes (max 1-2 g)
RepeatCan repeat as needed (up to hourly) based on response
Maintenance infusion10-20 mg/kg/h (adult equivalent: 500 mg/h or 8 mg/kg/h) up to 7 days
EndpointImproved mental status, respiratory rate/effort, heart rate, decreased secretions
  • Give as early as possible - before aging occurs
  • If fat-soluble OPs are involved, patient may require prolonged infusion for weeks while awaiting new AChE synthesis
  • Discontinue trial by withdrawing pralidoxime; if symptoms recur, continue therapy
    • Rosen's Emergency Medicine, p. 1492-1493; Tintinalli's Emergency Medicine, p. 1344

Step 5: Benzodiazepines for Seizures

  • Seizures are treated with benzodiazepines (diazepam, lorazepam, or midazolam)
  • Phenytoin is NOT recommended for OP-induced seizures (no evidence of benefit)
  • Standard pediatric weight-based dosing applies

Step 6: GI Decontamination

  • Activated charcoal (1 g/kg, max 50 g) may be considered for recent oral ingestion (<1 hour) if airway is protected
  • Gastric lavage rarely indicated and poses aspiration risk
  • DO NOT induce vomiting

Cholinesterase Levels (Lab)

  • Plasma butyrylcholinesterase - more available but less specific; easier to run
  • RBC acetylcholinesterase - more accurate marker of synaptic inhibition
  • Important: Do NOT wait for results before starting treatment. Treatment is clinical. Baseline variability and lack of standardized normal ranges limit these assays.

Disposition

SeverityDisposition
Mild, asymptomaticObserve in ED 4-6 hours minimum
Any symptomsAdmit for monitoring
Moderate-severePediatric ICU
Respiratory failure, large atropine requirementsPICU with ventilator
Most patients respond to pralidoxime with rising AChE levels within 48 hours. If no post-hypoxic brain damage and early treatment, symptomatic recovery occurs within approximately 10 days. Fat-soluble agents may require weeks of supportive care. - Tintinalli's Emergency Medicine, p. 1344

Special Pediatric Notes

  • Carbamates (e.g., carbaryl) differ from OPs: they do NOT cause aging and spontaneously dissociate from AChE. Pralidoxime is generally not recommended for carbamate poisoning
  • Diazinon and chlorpyrifos were removed from household use in the US in 2000 due to neurotoxicity on developing brains, but remain in use globally
  • Consider child abuse or intentional poisoning if exposure history is inconsistent
  • Always contact Poison Control (1-800-222-1222) early - they assist with specific product ingredient identification and management guidance

Quick Reference Summary Card

OP Poisoning in Peds:
1. Decontaminate (remove clothes, wash skin) + PPE for staff
2. Airway first - early intubation; avoid succinylcholine
3. ATROPINE: 0.05 mg/kg IV → double q5-10min → titrate to DRY secretions
4. PRALIDOXIME: 25-50 mg/kg IV over 30 min → infusion 10-20 mg/kg/h
5. BENZOS for seizures
6. PICU admission for moderate-severe cases
Sources: Tintinalli's Emergency Medicine, pp. 1342-1344; Rosen's Emergency Medicine, pp. 1492-1494
This is a shared conversation. Sign in to Orris to start your own chat.